[Therapy and prognosis of testicular tumors: the seminoma, results from radiation therapy in 100 patients (author's transl)].
Hundred patients with seminoma were irradiated in our clinic between 1963 and 1975. The 5-year survival rate corresponds to the rate of freedom from disease. It amounts to 97% for Stage I, 84% for Stage II, 55% for Stage III, O for Stage IV, and to 85% for all stages. These results are obtained by means of consequent radiation therapy. It is not cleared up wether general prophylactic irradiation improves the prognosis of mediastinal and supraclavicular affections. No complications may be expected on account of therapeutic doses, as the sensitivity to radiation is high. It is possible, on these grounds, in generalized stages, to take into consideration the total-body irradiation with low doses as an alternative to chemotherapy.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D004407:Dysgerminoma / Q000175:diagnosis / Q000532:radiotherapy*; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011879:Radiotherapy Dosage; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*
Therapie und Prognose der Hodentumoren: Das Seminom. Ergebnisse der Radiotherapie bei 100 Patienten.